Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    14645512 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia
Condition: Acute Myelocytic Leukemia
Intervention: Drug: ribavirin

Indicates status has not been verified in more than two years